Interobserver variability in interim PET assessment in Hodgkin lymphoma-reasons and solutions.

Interobserver variability in interim PET assessment in Hodgkin lymphoma-reasons and solutions.

<h4>Introduction</h4>Interim PET (iPET) assessment is important for response adaptation in Hodgkin lymphoma (HL). The current standard for iPET assessment is the Deauville score (DS). The aim of our study was to evaluate the causes of interobserver variability in assigning the DS for iPE...

Descripció completa

Dades bibliogràfiques
Autors principals:	Thomas W Georgi, Lars Kurch, Dirk Hasenclever, Victoria S Warbey, Lucy Pike, John Radford, Osama Sabri, Regine Kluge, Sally F Barrington
Format:	Article
Idioma:	English
Publicat:	Public Library of Science (PLoS) 2023-01-01
Col·lecció:	PLoS ONE
Accés en línia:	https://doi.org/10.1371/journal.pone.0283694

Ítems similars

Quantitative assessment of interim PET in Hodgkin lymphoma: An evaluation of the qPET method in adult patients in the RAPID trial.
per: Thomas W Georgi, et al.
Publicat: (2020-01-01)

Quantitative evaluation of interim positron emission tomography in peripheral T-cell lymphoma
per: Lars Kurch, et al.
Publicat: (2021-09-01)

Inter-Reader Reliability of Early FDG-PET/CT Response Assessment Using the Deauville Scale after 2 Cycles of Intensive Chemotherapy (OEPA) in Hodgkin's Lymphoma.
per: Regine Kluge, et al.
Publicat: (2016-01-01)

Interim FDG-PET Scan in Hodgkin's Lymphoma: Hopes and Caveats
per: M. André, et al.
Publicat: (2011-01-01)

Automatic classification of lymphoma lesions in FDG-PET–Differentiation between tumor and non-tumor uptake
per: Thomas W Georgi, et al.
Publicat: (2022-01-01)

Automatic classification of lymphoma lesions in FDG-PET-Differentiation between tumor and non-tumor uptake.
per: Thomas W Georgi, et al.
Publicat: (2022-01-01)

End-of-treatment PET in early-stage Hodgkin lymphoma: valuable in addition to interim PET
per: Karan L. Chohan, et al.
Publicat: (2022-12-01)

Interim FDG-PET/CT for therapy monitoring and prognostication in Hodgkin’s Lymphoma
per: Akram Al-Ibraheem, et al.
Publicat: (2022-10-01)

Interim PET for prognosis in adults with Hodgkin lymphoma: A prognostic factor exemplar review
per: Skoetz, N, et al.
Publicat: (2017)

Interim PET-directed therapy in limited-stage Hodgkin lymphoma initially treated with ABVD
per: Diego Villa, et al.
Publicat: (2018-12-01)

Prevention of activated brown adipose tissue on 18F-FDG-PET scans of young lymphoma patients: results of an ancillary study within the EuroNet-PHL-C2 trial
per: C. Pötzsch, et al.
Publicat: (2023-12-01)

Classical Hodgkin Lymphoma: A Joint Clinical and PET Model to Predict Poor Responders at Interim Assessment
per: Elizabeth Katherine Anna Triumbari, et al.
Publicat: (2022-09-01)

Whole-body [18F]-FDG-PET/MRI for staging of pediatric non-Hodgkin lymphoma: first results from a single-center evaluation
per: L. Kurch, et al.
Publicat: (2021-07-01)

Interim-treatment quantitative PET parameters predict progression and death among patients with hodgkin's disease
per: Tseng Diane, et al.
Publicat: (2012-01-01)

Hodgkin lymphoma: hypodense lesions in mediastinal masses
per: Adrian Damek, et al.
Publicat: (2024-06-01)

Interim PET-results for prognosis in adults with Hodgkin lymphoma: a systematic review and meta-analysis of prognostic factor studies
per: Aldin, A, et al.
Publicat: (2019)

Interim PET‐results for prognosis in adults with Hodgkin lymphoma: A systematic review and meta‐analysis of prognostic factor studies
per: Aldin, A, et al.
Publicat: (2020)

P105: Decisional role of interim PET in relapsed/refractory classical Hodgkin Lymphoma treated with four begev cycles
per: Chiara Rusconi, et al.
Publicat: (2022-10-01)

S225: CIRCULATING TUMOR DNA IS A PROGNOSTIC BIOMARKER AT BASELINE AND IMPROVES THE ACCURACY OF INTERIM PET IN CLASSIC HODGKIN LYMPHOMA
per: M. C. Pirosa, et al.
Publicat: (2022-06-01)

Does Interim PET Scan After 2 Cycles of ABVD Predict Outcome in Hodgkin Lymphoma? Real-World Evidence
per: Arun Seshachalam, et al.
Publicat: (2019-12-01)

P033 (0007) SINGLE CENTER ANALYSIS OF NODULAR LYMPHOCYTE PREDOMINANT HODGKIN LYMPHOMA: FOCUS ON R-ABVD AND INTERIM PET
Publicat: (2018-10-01)

P1070: DECISIONAL ROLE OF INTERIM PET IN RELAPSED/REFRACTORY CLASSICAL HODGKIN LYMPHOMA TREATED WITH BEGEV CHEMOTHERAPY AS FIRST SALVAGE
per: Chiara Rusconi, et al.
Publicat: (2023-08-01)

FDG-PET as a biomarker for early response in diffuse large B-cell lymphoma as well as in Hodgkin lymphoma? Ready for implementation in clinical practice?
per: Josée M. Zijlstra, et al.
Publicat: (2016-11-01)

Interim results of a UK NCRI randomised trial comparing involved field radiotherapy with no further treatment after 3 cycles ABVD and a negative PET scan in clinical stages IA/IIA Hodgkin lymphoma
per: Radford, J, et al.
Publicat: (2007)

Maximum tumor diameter is associated with event-free survival in PET-negative patients with stage I/IIA Hodgkin lymphoma
per: Tim M. Illidge, et al.
Publicat: (2020-01-01)

P108: Integrating baseline circulating tumor DNA with interim PET improves outcome prediction in relapsed/refractory classical Hodgkin lymphoma
per: Eleonora Calabretta, et al.
Publicat: (2022-10-01)

P026 (0057) INTERIM- PET RESULTS FOR PROGNOSIS IN ADULTS WITH HODGKIN LYMPHOMA: A PROGNOSTIC FACTOR EXEMPLAR REVIEW (PRELIMINARY RESULTS)
Publicat: (2018-10-01)

P004: Advanced stage classical Hodgkin lymphoma (cHL) patients with a positive interim-PET (PET-2) Deauville score (DS) 5 after 2 ABVD cycles: A pooled analysis of individual patient data of three multicenter trials
per: Simonetta Viviani, et al.
Publicat: (2022-10-01)

Vital Hepatic Lymphoma Residuum or Excessive Immune Response? Challenging Treatment Decisions in a Patient With Systemic Lupus Erythematosus and Liver-Dominant Diffuse Large B-Cell Lymphoma: Case Report
per: Lars Kurch, et al.
Publicat: (2022-01-01)

The role of FDG-PET in Hodgkin lymphoma
per: Edyta Subocz, et al.
Publicat: (2017-06-01)

Healthy tissue metabolism assessed by [18F]FDG PET/CT as a marker of prognosis and adverse events in advanced Hodgkin lymphoma patients
per: Afnan A. Malaih, et al.
Publicat: (2024-06-01)

The importance of harmonizing interim positron emission tomography in non-Hodgkin lymphoma: focus on the Deauville criteria
per: Elske Quak, et al.
Publicat: (2014-06-01)

The predictive role of interim positron emission tomography for Hodgkin lymphoma treatment outcome is confirmed using the interpretation criteria of the Deauville five-point scale
per: Andrea Gallamini, et al.
Publicat: (2014-06-01)

The utility of PET/CT with 18F-FDG in the study of Hodgkin's lymphoma and non-Hodgkin's lymphoma
per: Marta Milhões, et al.
Publicat: (2015-11-01)

Risk and Response Adapted Treatment Guidelines for Managing First Relapsed and Refractory Classical Hodgkin Lymphoma in Children and Young People. Recommendations from the EuroNet Pediatric Hodgkin Lymphoma Group
per: Stephen Daw, et al.
Publicat: (2020-02-01)

T020: Interim PET-guided treatment of early-stage nodular lymphocyte-predominant Hodgkin lymphoma: a subgroup analysis of the GHSG HD16 and HD17 studies
per: Dennis A. Eichenauer, et al.
Publicat: (2022-10-01)

Interobserver delineation uncertainty in involved-node radiation therapy (INRT) for early-stage Hodgkin lymphoma: on behalf of the Radiotherapy Committee of the EORTC lymphoma group
per: Aznar, M, et al.
Publicat: (2017)

MRI versus CT and PET/CT in the Preoperative Assessment of Hodgkin and Non-Hodgkin Lymphomas
per: Francesca Maccioni, et al.
Publicat: (2021-10-01)

Fluorine-18 fluorodeoxyglucose PET-CT for extranodal staging of non-Hodgkin and Hodgkin lymphoma
per: Özgür Ömür, et al.
Publicat: (2014-03-01)

Machine Learning to Predict Interim Response in Pediatric Classical Hodgkin Lymphoma Using Affordable Blood Tests
per: Jennifer A. Geel, et al.
Publicat: (2024-10-01)